2025年全球無管胰島素幫浦市場報告

近年來，無管胰島素幫浦市場規模快速擴張，從2024年的18.4億美元成長到2025年的22億美元，複合年成長率達19.5%。預測期內的成長可歸因於糖尿病盛行率的上升、對便捷、隱藏的胰島素給藥方式的需求不斷成長、糖尿病管理意識的增強、報銷政策的加強、患者對無痛胰島素給藥的偏好以及家庭醫療保健解決方案的擴展。

無管胰島素幫浦市場規模預計將在未來幾年快速成長，到2029年將達到44.4億美元，複合年成長率為19.1%。預測期內的成長可歸因於對謹慎易用的胰島素輸送系統的需求不斷成長、對個性化糖尿病管理的日益重視、先進胰島素設備的報銷政策的擴大以及透過數位健康舉措不斷提高的認知度。預測期內的主要趨勢包括人工智慧血糖監測的整合、與智慧型手機應用程式的連接性增強、貼片設備的小型化、閉合迴路系統的採用以及穿戴式健康技術的廣泛應用。

無管胰島素幫浦是專為糖尿病患者設計的穿戴式醫療設備，無需外部導管即永續輸送胰島素。它直接佩戴在皮膚上，並透過手持控制器進行無線通訊，為胰島素給藥提供了一種更便捷、更隱密的方法。

無管胰島素幫浦主要分為穿戴式和植入式。穿戴式幫浦是一種佩戴在身上的緊湊型裝置，可連續皮下輸送短效胰島素，最大限度地減少每日多次注射的需求。這類幫浦採用持續血糖監測 (CGM)、整合幫浦系統和標準無管胰島素幫浦等技術，供醫院、藥局和電商平台等終端用戶使用。

美國關稅的快速上漲以及持續至2025年春季的貿易摩擦，對醫療設備產業產生了重大影響，尤其對進口診斷影像設備零件、手術用不銹鋼和塑膠耗材的影響。醫院和診所抵制漲價，擠壓了製造商的淨利率。監管障礙加劇了這個問題，因為與關稅相關的供應商變更通常需要設備重新認證，從而延緩了產品上市時間。企業正在透過雙重採購關鍵零件、擴大國內商品化生產以及加快具成本效益材料的研發來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供無管胰島素幫浦市場統計數據，例如全球市場規模、各地區市場佔有率、競爭對手的市場佔有率、詳細的無管胰島素幫浦細分市場、市場趨勢以及無管胰島素幫浦行業的商機，為您提供在無管胰島素幫浦行業取得成功所需的數據。本無管胰島素幫浦市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

糖尿病盛行率的上升預計將在未來幾年推動無管胰島素幫浦市場的成長。糖尿病是一種慢性疾病，其特徵是高血糖，因為身體無法產生或有效利用胰島素。糖尿病患者的增加在很大程度上與肥胖率的上升有關，而肥胖率的上升與不良飲食和缺乏運動密切相關。無管胰島素幫浦透過提供持續劑量的胰島素並有效調節血糖值（無需每天多次注射）來幫助控制糖尿病。例如，美國公共衛生研究機構健康指標與評估研究所在 2023 年 6 月報告稱，全球有超過 5 億人患有糖尿病。預計到 2050 年，這一數字將增加一倍以上，達到 13 億。因此，糖尿病盛行率的上升刺激了對無管胰島素幫浦的需求。

無管胰島素幫浦市場的新興市場正專注於開發先進的解決方案，例如基礎胰島素艙，為僅需要背景胰島素的 2 型糖尿病患者提供便利且經濟高效的胰島素輸送。基礎胰島素艙是穿戴式泵，可輸送持續的背景胰島素以幫助控制血糖值，主要針對第 2 型糖尿病患者。 2023 年 4 月，美國醫療設備公司 Insulet Corporation 推出了 Omnipod GO，這是一款胰島素輸送裝置，核准用於通常每天接受長效胰島素注射的成年 2 型糖尿病患者。 Omnipod GO 是一種穿戴式的獨立設備，可在 72 小時內輸送一致、快速起效的胰島素劑量。無管防水艙預先設定了 7 個每日劑量，範圍從 10 到 40 個單位，無需移動設備即可使用。

2023年1月，總部位於美國的胰島素輸送和糖尿病技術公司Tandem Diabetes Care收購了AMF Medical SA，收購金額未揭露。此次收購透過Sigi幫浦的可充電設計減少電池浪費，同時擴展了Tandem先進的胰島素輸送解決方案組合，從而支持了Tandem的永續性舉措。總部位於瑞士的AMF Medical SA專注於生產可重複使用的貼片（無管）胰島素幫浦。

無管胰島素幫浦市場涵蓋輸液器、插入裝置、黏貼式膠囊以及手持式或智慧型手機控制器的銷售。該市場的價值指的是“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場的商品價值還包括商品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球無管胰島素幫浦：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 最終用途產業分析
• 全球無管胰島素幫浦市場：成長率分析
• 全球無管胰島素幫浦市場表現：規模與成長，2019-2024
• 全球無管胰島素幫浦市場預測：規模與成長，2024-2029年，2034年
• 全球無管胰島素幫浦：總目標市場（TAM）

第6章 市場細分

• 全球無管胰島素幫浦市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 穿戴式胰島素泵
• 植入式胰島素泵
• 全球無管胰島素幫浦市場：按技術、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 持續血糖監測（CGM）整合泵
• 標準無內胎泵
• 全球無管胰島素幫浦市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 醫院
• 藥局
• 電子商務
• 其他最終用戶
• 全球無管胰島素幫浦市場：穿戴式胰島素幫浦細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 貼片幫浦
• 遙控泵浦
• 支援藍牙的泵
• 一次性泵浦
• 可重複使用泵浦
• 全球無管胰島素幫浦市場：依植入式胰島素幫浦類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
• 可程式設計植入式泵
• 可再填充植入式泵
• 基於電子機械系統（MEMS）的泵
• 長效植入幫浦
• 生物相容性塗層泵

第7章 區域和國家分析

• 全球無管胰島素幫浦市場：區域分析、預測及預測，2019-2024 年、2024-2029 年、2034 年
• 全球無管胰島素幫浦市場：依國家/地區、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 無管胰島素幫浦市場：競爭格局
• 無管胰島素幫浦市場：公司簡介
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• Becton Dickinson & Company
• Fresenius Kabi AG
• Terumo Corporation
• Insulet Corporation
• Tandem Diabetes Care Inc.
• Ypsomed AG
• Ascensia Diabetes Care
• MicroTech Medical
• Menarini Diagnostics
• Bigfoot Biomedical
• Debiotech SA
• Medtrum Technologies Inc.
• Diabeloop
• SOOIL Development
• Beta Bionics

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

• 2029年無管胰島素幫浦市場：提供新機會的國家
• 2029年無管胰島素幫浦市場：細分市場帶來新機會
• 2029年無管胰島素幫浦市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

A tubeless insulin pump is a wearable medical device designed for people with diabetes to provide continuous insulin delivery without the use of external tubing. It adheres directly to the skin and communicates wirelessly with a handheld controller, offering a more convenient and discreet method of insulin administration.

The primary types of tubeless insulin pumps include wearable and implantable insulin pumps. Wearable pumps are compact devices worn on the body that administer continuous doses of short-acting insulin subcutaneously, minimizing the need for multiple daily injections. These pumps utilize technologies such as continuous glucose monitoring (CGM), integrated pump systems, and standard tubeless pumps, and are utilized by end users including hospitals, pharmacies, e-commerce platforms, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The tubeless insulin pump market research report is one of a series of new reports from The Business Research Company that provides tubeless insulin pump market statistics, including the tubeless insulin pump industry global market size, regional shares, competitors with the tubeless insulin pump market share, detailed tubeless insulin pump market segments, market trends, and opportunities, and any further data you may need to thrive in the tubeless insulin pump industry. This tubeless insulin pump market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tubeless insulin pump market size has grown rapidly in recent years. It will grow from $1.84 billion in 2024 to $2.20 billion in 2025 at a compound annual growth rate (CAGR) of 19.5%. The growth in the historic period can be credited to the increasing prevalence of diabetes, rising demand for convenient and discreet insulin delivery methods, growing awareness about diabetes management, enhanced reimbursement policies, patient preference for pain-free insulin administration, and the expansion of home healthcare solutions.

The tubeless insulin pump market size is expected to see rapid growth in the next few years. It will grow to $4.44 billion in 2029 at a compound annual growth rate (CAGR) of 19.1%. The growth in the forecast period can be attributed to rising demand for discreet and user-friendly insulin delivery systems, increased focus on personalized diabetes management, expansion of reimbursement policies for advanced insulin devices, and growing awareness through digital health initiatives. Major trends in the forecast period include the integration of AI-powered glucose monitoring, enhanced smartphone app connectivity, miniaturization of patch devices, adoption of closed-loop systems, and wider use of wearable health technologies.

The rising prevalence of diabetes is expected to drive the growth of the tubeless insulin pump market in the coming years. Diabetes is a chronic condition characterized by high blood sugar due to the body's inability to produce or effectively use insulin. The increase in diabetes cases is largely linked to rising obesity rates, which are strongly associated with poor diet and physical inactivity. Tubeless insulin pumps help manage diabetes by delivering continuous, controlled doses of insulin without the need for multiple daily injections, effectively regulating blood sugar levels. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people worldwide were living with diabetes. This number is projected to more than double, reaching 1.3 billion by 2050. Consequently, the growing prevalence of diabetes is fueling demand for tubeless insulin pumps.

Key players in the tubeless insulin pump market are focusing on developing advanced solutions, such as basal-only insulin pods, to provide simplified and cost-effective insulin delivery for individuals with type 2 diabetes who require only background insulin support. A basal-only insulin pod is a wearable pump that delivers a continuous background dose of insulin to help control blood sugar levels, primarily for those with type 2 diabetes. In April 2023, Insulet Corporation, a US-based medical device company, launched Omnipod GO, an insulin delivery device approved for use in adults with type 2 diabetes who would normally receive daily long-acting insulin injections. Omnipod GO is a wearable, independent device that delivers a constant rate of rapid-acting insulin for 72 hours. The tubeless and waterproof pod comes in seven pre-programmed daily rates ranging from 10 to 40 units and operates without the need for a mobile device.

In January 2023, Tandem Diabetes Care, a US-based insulin delivery and diabetes technology company, acquired AMF Medical SA for an undisclosed amount. This acquisition supports Tandem's sustainability initiatives by reducing battery waste through the Sigi pump's rechargeable design while expanding its portfolio of advanced insulin delivery solutions. AMF Medical SA, based in Switzerland, specializes in the manufacture of reusable patch (tubeless) insulin pumps.

Major players in the tubeless insulin pump market are F. Hoffmann-La Roche AG, Sanofi SA, Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Becton Dickinson & Company, Fresenius Kabi AG, Terumo Corporation, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Ascensia Diabetes Care, MicroTech Medical, Menarini Diagnostics, Bigfoot Biomedical, Debiotech SA, Medtrum Technologies Inc., Diabeloop, SOOIL Development, and Beta Bionics.

North America was the largest region in the tubeless insulin pump market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tubeless insulin pump market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tubeless insulin pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tubeless insulin pump market consists of sales of infusion sets, insertion tools, adhesives pods, and handheld or smartphone-based controllers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tubeless Insulin Pump Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tubeless insulin pump market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tubeless insulin pump ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tubeless insulin pump market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Wearable Insulin Pump; Implantable Insulin Pump
• 2) By Technology: Continuous Glucose Monitoring (CGM) Integrated Pumps; Standard Tubeless Pumps
• 3) By End User: Hospitals; Pharmacies; E-Commerce; Other End Users
• Subsegments:
• 1) By Wearable Insulin Pump: Patch Pumps; Remote-Controlled Pumps; Bluetooth-Enabled Pumps; Disposable Pumps; Reusable Pumps
• 2) By Implantable Insulin Pump: Programmable Implantable Pumps; Refillable Implantable Pumps; Microelectromechanical System (MEMS)-Based Pumps; Long-Acting Implantable Pumps; Biocompatible Coated Pumps
• Companies Mentioned: F. Hoffmann-La Roche AG; Sanofi SA; Abbott Laboratories; Medtronic plc; Eli Lilly and Company; Becton Dickinson & Company; Fresenius Kabi AG; Terumo Corporation; Insulet Corporation; Tandem Diabetes Care Inc.; Ypsomed AG; Ascensia Diabetes Care; MicroTech Medical; Menarini Diagnostics; Bigfoot Biomedical; Debiotech SA; Medtrum Technologies Inc.; Diabeloop; SOOIL Development; Beta Bionics.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tubeless Insulin Pump Market Characteristics

3. Tubeless Insulin Pump Market Trends And Strategies

4. Tubeless Insulin Pump Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tubeless Insulin Pump Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tubeless Insulin Pump PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tubeless Insulin Pump Market Growth Rate Analysis
• 5.4. Global Tubeless Insulin Pump Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tubeless Insulin Pump Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tubeless Insulin Pump Total Addressable Market (TAM)

6. Tubeless Insulin Pump Market Segmentation

• 6.1. Global Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wearable Insulin Pump
• Implantable Insulin Pump
• 6.2. Global Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Continuous Glucose Monitoring (CGM) Integrated Pumps
• Standard Tubeless Pumps
• 6.3. Global Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Pharmacies
• E-Commerce
• Other End Users
• 6.4. Global Tubeless Insulin Pump Market, Sub-Segmentation Of Wearable Insulin Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Patch Pumps
• Remote-Controlled Pumps
• Bluetooth-Enabled Pumps
• Disposable Pumps
• Reusable Pumps
• 6.5. Global Tubeless Insulin Pump Market, Sub-Segmentation Of Implantable Insulin Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Programmable Implantable Pumps
• Refillable Implantable Pumps
• Microelectromechanical System (MEMS)-Based Pumps
• Long-Acting Implantable Pumps
• Biocompatible Coated Pumps

7. Tubeless Insulin Pump Market Regional And Country Analysis

• 7.1. Global Tubeless Insulin Pump Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tubeless Insulin Pump Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tubeless Insulin Pump Market

• 8.1. Asia-Pacific Tubeless Insulin Pump Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tubeless Insulin Pump Market

• 9.1. China Tubeless Insulin Pump Market Overview
• 9.2. China Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tubeless Insulin Pump Market

• 10.1. India Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tubeless Insulin Pump Market

• 11.1. Japan Tubeless Insulin Pump Market Overview
• 11.2. Japan Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tubeless Insulin Pump Market

• 12.1. Australia Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tubeless Insulin Pump Market

• 13.1. Indonesia Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tubeless Insulin Pump Market

• 14.1. South Korea Tubeless Insulin Pump Market Overview
• 14.2. South Korea Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tubeless Insulin Pump Market

• 15.1. Western Europe Tubeless Insulin Pump Market Overview
• 15.2. Western Europe Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tubeless Insulin Pump Market

• 16.1. UK Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tubeless Insulin Pump Market

• 17.1. Germany Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tubeless Insulin Pump Market

• 18.1. France Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tubeless Insulin Pump Market

• 19.1. Italy Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tubeless Insulin Pump Market

• 20.1. Spain Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tubeless Insulin Pump Market

• 21.1. Eastern Europe Tubeless Insulin Pump Market Overview
• 21.2. Eastern Europe Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tubeless Insulin Pump Market

• 22.1. Russia Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tubeless Insulin Pump Market

• 23.1. North America Tubeless Insulin Pump Market Overview
• 23.2. North America Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tubeless Insulin Pump Market

• 24.1. USA Tubeless Insulin Pump Market Overview
• 24.2. USA Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tubeless Insulin Pump Market

• 25.1. Canada Tubeless Insulin Pump Market Overview
• 25.2. Canada Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tubeless Insulin Pump Market

• 26.1. South America Tubeless Insulin Pump Market Overview
• 26.2. South America Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tubeless Insulin Pump Market

• 27.1. Brazil Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tubeless Insulin Pump Market

• 28.1. Middle East Tubeless Insulin Pump Market Overview
• 28.2. Middle East Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tubeless Insulin Pump Market

• 29.1. Africa Tubeless Insulin Pump Market Overview
• 29.2. Africa Tubeless Insulin Pump Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tubeless Insulin Pump Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tubeless Insulin Pump Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tubeless Insulin Pump Market Competitive Landscape And Company Profiles

• 30.1. Tubeless Insulin Pump Market Competitive Landscape
• 30.2. Tubeless Insulin Pump Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Tubeless Insulin Pump Market Other Major And Innovative Companies

• 31.1. Becton Dickinson & Company
• 31.2. Fresenius Kabi AG
• 31.3. Terumo Corporation
• 31.4. Insulet Corporation
• 31.5. Tandem Diabetes Care Inc.
• 31.6. Ypsomed AG
• 31.7. Ascensia Diabetes Care
• 31.8. MicroTech Medical
• 31.9. Menarini Diagnostics
• 31.10. Bigfoot Biomedical
• 31.11. Debiotech SA
• 31.12. Medtrum Technologies Inc.
• 31.13. Diabeloop
• 31.14. SOOIL Development
• 31.15. Beta Bionics

32. Global Tubeless Insulin Pump Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tubeless Insulin Pump Market

34. Recent Developments In The Tubeless Insulin Pump Market

35. Tubeless Insulin Pump Market High Potential Countries, Segments and Strategies

• 35.1 Tubeless Insulin Pump Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tubeless Insulin Pump Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tubeless Insulin Pump Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer